Is brachytherapy possible in eye tumors?
Brachytherapy has been applied for many years in order to prevent surgical removal of the eye in eye tumors and to provide cancer control by preserving useful vision.
Patient selection is very important.
The most common uses of eye plaque brachytherapy are uveal melanomas, retinoblastoma, solitary choroidal metastases, diffuse choroidal hemangioma, treatment-resistant retinal vascular tumors (retinal hemangioblastoma, vasoproliferative tumors, etc.)
Who will evaluate the patient?
After the evaluation of the ophthalmologist dealing with ocular oncology, i.e. eye tumors, and then the completion of body scanning and examinations by the radiation oncologist, the patient is prepared for the procedure. The decision is made after the determination of the appropriate gold plate for the patient and the preparation of the plan by the physics unit.
Is post-treatment follow-up important?
Certainly. As in all oncological treatments, close follow-up of the patient is very important in eye brachytherapy. Early detection of possible side effects and, if necessary, intraocular injections or laser applications to preserve beneficial vision and follow-up the response of the tumor are important.
